1st Quarter - Report — AKIN GUMP STRAUSS HAUER & FELD for CENTRIENT PHARMACEUTICALS LLC (2026)

Firm

AKIN GUMP STRAUSS HAUER & FELD

Client

CENTRIENT PHARMACEUTICALS LLC

Income

$60,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Lobbyist	Covered position, as disclosed
SAM OLSWANGER	—

Contacted: Natl Security Council (NSC); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Natl Economic Council (NEC)

Trade (domestic/foreign) TRD

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Lobbyist	Covered position, as disclosed
SAM OLSWANGER	—

Contacted: Office of Management & Budget (OMB); Natl Security Council (NSC); Natl Economic Council (NEC); SENATE

Health Issues HCR

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Lobbyist	Covered position, as disclosed
SAM OLSWANGER	—

Contacted: Natl Security Council (NSC); Natl Economic Council (NEC); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Pharmacy PHA

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Lobbyist	Covered position, as disclosed
SAM OLSWANGER	—

Contacted: Natl Economic Council (NEC); SENATE; Office of Management & Budget (OMB); Natl Security Council (NSC); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.